Arjen Lindenholz

151 Intracranial Atherosclerotic Burden and Cerebral Parenchymal Changes at 7T MRI 6 18. Yang WJ, Wong KS, Chen XY. Intracranial Atherosclerosis: From Microscopy to High- Resolution Magnetic Resonance Imaging. Journal of Stroke 2017;19:249-60. 19. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. The Lancet Neurology 2013;12:483-97. 20. Van VeluwSJ, ShihAY, Smith EE, et al. Detection, risk factors, and functional consequences of cerebral microinfarcts. Lancet Neurology 2017;16:730-40. 21. Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke and Vascular Neurology 2016;1:83-92. 22. Ihara M, Yamamoto Y. Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease. Stroke 2016;47:554-60. 23. Van der Kolk AG, Hendrikse J, Brundel M, Biessels GJ, Smit EJ, Visser F. Multi-sequence whole-brain intracranial vessel wall imaging at 7.0 tesla. European Radiology 2013;23:2996-3004. 24. Adams HP, Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41. 25. Lindenholz A, van der Kolk AG, van der Schaaf IC, et al. Intracranial Atherosclerosis Assessed with 7-T MRI: Evaluation of Patients with Ischemic Stroke or Transient Ischemic Attack. Radiology 2020;295:162-70. 26. Klein S, Staring M, Murphy K, Viergever MA, Pluim JP. elastix: a toolbox for intensity-based medical image registration. IEEE Transactions on Medical Imaging 2010;29:196-205. 27. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology 2013;12:822-38. 28. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR American Journal of Roentgenology 1987;149:351-6. 29. Wardlaw JM, Dennis MS, Warlow CP, Sandercock PA. Imaging appearance of the symptomatic perforating artery in patients with lacunar infarction: occlusion or other vascular pathology? Annals of Neurology 2001;50:208-15. 30. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. The Lancet Neurology 2010;9:689-701. 31. Harteveld AA, De Cocker LJ, Dieleman N, et al. High-resolution postcontrast time-of-flight MR angiography of intracranial perforators at 7.0 Tesla. PLoS One 2015;10:e0121051. 32. Kwon HM, Lynn MJ, Turan TN, et al. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. JAMA Neurology 2016;73:36-42. 33. Bang OY, Chung JW, Ryoo S, et al. Brain microangiopathy and macroangiopathy share common risk factors and biomarkers. Atherosclerosis 2016;246:71-7.